Press releases and articles

New e-mail addresses for all Euroimmun employees

Following the successful launch of our new design last summer, another change at Euroimmun and IDS takes place, which makes our affiliation to Revvity, Inc. more visible.

Homer-3 autoimmunity: Insights from a newly identified case

A new case of Homer-3 autoimmunity has been described, expanding the still limited body of knowledge about this rare autoimmune cerebellar disorder. The case was reported in the Journal of ...

Anti-ITPR1 autoimmunity – a case mimicking Alzheimer’s disease

Autoimmunity targeting inositol 1,4,5-triphosphate receptor type 1 (ITPR1) was identified as a potential cause of cognitive decline resembling Alzheimer’s disease in a retrospective case study. The ...

Differentiated alphavirus infection diagnostics: an outlook for epidemiology and patient care

For some time now, alphaviruses, including well-known viruses like chikungunya virus, have not only been a problem in tropical regions. Due to climate change and the associated spread of mosquitoes as ...

High concordance of serological methods for EBV staging

A new collaborative study by Euroimmun and researchers in Türkiye reports that both ELISA and immunoblot show excellent agreement with the reference standard — indirect immunofluorescence assay (IFA) ...

Serological diagnostics of Oropouche virus infections: Euroimmun Brazil launches new ANVISA-approved ELISAs

Climate change, population growth, global travel and shifting lifestyles all increase both how likely and how quickly infectious diseases spread. This is especially true for arboviruses, which are ...

Robust performance of serological tests for coeliac disease in Tunisia

Serological tests for coeliac disease-specific antibodies showed exceptionally high sensitivity and specificity in a Tunisian cohort, underscoring their diagnostic utility. The recently published ...

Euroimmun sets new standards in serological neurological diagnostics

Long anticipated – now available: the neurology portfolio for the UNIQO 160, our all-in-one automated IFA system, has been expanded by nine more indirect immunofluorescence assays (IFA). While the ...

Clarity on the floor: differentiating dermal-binding autoantibodies

A newly published international study has demonstrated the high sensitivity of the Euroimmun Dermal Binder Mosaic 1 for detecting antibodies against laminin β4, laminin 332 and collagen type VII. The ...

Welcome to the Future of Learning: Euroimmun Campus is Live!

The way we learn has changed dramatically in recent years. During the pandemic, online training became essential, and now, we’re taking the next big step to make learning smarter and more efficient. ...

Back to top